Early [11C]flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy

Stroke

Volumn 31, Issue 2, 2000, Pages 366-369

  Heiss, Wolf Dieter ^a   Kracht, Lutz ^a   Grond, Martin ^a   Rudolf, Jobst ^a   Bauer, Bernd ^a   Wienhard, Klaus ^a   Pawlik, Gunter ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Flumazenil; Ligands; Penumbra; Stroke, acute; Stroke, ischemic; Thrombolytic therapy; Tomography, emission computed

Indexed keywords

ALTEPLASE; FLUMAZENIL; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN CORTEX; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY;

AGED; CEREBRAL CORTEX; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; FLUMAZENIL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033621655     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.2.366     Document Type: Article

References (27)

1. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723-725.
2. Heiss W-D, Graf R. The ischemic penumbra. Curr Opin Neurol. 1994; 7:11-19.
3. Hossmann K-A. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
5. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M, for the European Cooperative ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-1025.
6. Schwartz RD, Yu X, Wagner J, Ehrmann M, Mileson BE. Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia. Neuropsychopharmacology. 1992;6: 119-125.
7. Abadie P, Baron JC. In vivo studies of the central benzodiazepine receptors in the human brain with positron emission tomography. In: Diksic M, Reba RC, eds. Radiopharmaceuticals and Brain Pathology Studies With PET and SPECT. Boca Raton Fla: CRC Press; 1991: 357-379.
8. Heiss W-D, Graf R, Fujita T, Ohta K, Bauer B, Löttgen J, Wienhard K. Early detection of irreversibly damaged ischemic tissue by flumazenil-PET in cats. Stroke. 1997;28:2045-2051.
9. Heiss W-D, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, Bauer B, Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke. 1998;29:454-461.
10. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, for the NINDS TPA Stroke Study Group. Improved reliability of the NIH Stroke Scale using video training. Stroke. 1994;25: 2220-2226.
11. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky I, Würker M, Heiss W-D. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med. 1994;35:2011-2018.
12. Stockhausen H-Mv, Pietrzyk U, Herholz K, Heiss W-D. Eine Methode zur oberflächenbezogenen Quantifizierung funktioneller Daten am Beispiel des menschlichen Kortex. In: Lehmann T, Scholl I, Spitzer K, eds. Bildverarbeitung in der Medizin. Aachen, Germany: Verl d Augustinus Buchhandlung; 1996:29-34.
13. 15O]water and PET without arterial blood sampling. In: Carson RE. Daube-Witherspoon ME, Herscovitch P, eds. Quantitative Functional Brain Imaging With Positron Emission Tomography. San Diego, Calif: Academic Press; 1998:151-154.
14. Baron JC, Rougemont D, Soussaline F, Bustany P, Crouzel C, Bousser MG, Comar D. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab. 1984;4: 140-149.
15. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985;5:600-608.
16. Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, Marchal G, Beil C, Pokrupa R, Diksic M, Meyer E, Gjedde A, Marrett S. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab. 1989;9:523-534.
17. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab. 1998;18:583-609.
18. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan GF, Scott AM, Bladin CF, McKay WJ, Donnan GA. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology. 1998;51:1617-1621.
19. Grotta JC, Alexandrov AV. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke. 1998;29:429-432.
20. Heiss W-D, Grond M, Thiel A, von Stockhausen H-M, Rudolf J, Ghaemi M, Löttgen J, Stenzel C, Pawlik G. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab. 1998;18:1298-1307.
21. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet. 1999;353:2036-2037.
22. Grond M, von Kummer R, Sobesky J, Schmülling S, Heiss W-D. Early computed-tomography abnormalities in acute stroke. Lancet. 1997;350: 1595-1596.
23. von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier DH, Hacke W. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997;205: 327-333.
24. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C. Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol. 1995;52:670-675.
25. Warach S, Boska M, Welch KMA. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke. Stroke. 1997;28: 481-482.
26. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, Saver JL. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174-1180.
27. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke. 1997;28: 124-132.